Xnos
xNOS is a biotechnology company that specializes in developing a multi-target therapeutic compound for treatment of sexual dysfunction in both women and men with type 1 and type 2 diabetes mellitus. The company was founded in 2016 and today has developed a novel target drug candidate Xoin® (xNOSniox). xNOS's comprehensive molecular expertise is expected to lead to a stream of future innovative commercial products. Nitric oxide technology is a key focus of xNOS's strategy. xNOS's technology base consists of validated and proprietary next-generation endothelial nitric oxide synthase (eNOS) activator therapies.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Xnos
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Xnos
1 distinct titles indexed · top 1 shown.
- 1co-founder
Sign up to unlock all 1 contacts at Xnos
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Xnos
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.